The prevention of graft-versus-host disease by the serum of liver retransplanted rats

By Shimizu Y.   Goto S.   Vari F.   Lord R.   Edwards-Smith C.   Chiba S.   Schlect D.   Buckley M.   Kusano M.   Kamada N.  

Transplant Immunology, Vol. 5, Iss. 1, 1997-03 ,pp. : 67-69

Elsevier

Access to resources Recommend Favorite

Evidence that the elevation of soluble MHC class I antigens in the serum precedes the onset of graft-versus-host disease and is correlated with the severity of the disease in rats

By Kimura T.   Enosawa S.   Kamada N.   Kobayashi E.   Toyama N.   Doy M.   Matsuzaki Y.   Tanaka N.   Osuga T.  

Transplant Immunology, Vol. 3, Iss. 4, 1995-12 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite

Graft Versus Host Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 539-545

Bentham Science Publishers

Access to resources Recommend Favorite

Confirmation of graft-versus-host disease by HLA typing after liver transplantation

By Arrieta A.   Maruri N.   Rinon M.   Fernandez J.R.   Ortiz de Urbina J.   Masdevall M.D.G.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 278-279

Elsevier

Access to resources Recommend Favorite

Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease

By Rinon M.   Maruri N.   Arrieta A.   Fernandez J.R.   Ortiz de Urbina J.   Garca Masdevall M.D.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 109-110

Elsevier

Access to resources Recommend Favorite